ADAP Analysis

Adaptimmune Therapeutics plc
Stock Exchange: NASDAQ
Sector: healthcare
1.82
Last session price
1.82
Price now
Currency: USD
Reporting currency: USD
ISIN: US00653A1079
INN:
.

ADAP financial statements

* Numbers in thousands
Capitalization * 281 698
EV * 811 924
Number of shares * 154 779
EPS -0,84
Revenue * 3 958
Net income * -130 092
Operating profit * -133 405
Total liabilities * 109 915
Net debt * -33 171
Total assets * 451 142
Equity * 341 227
Cash and investments * 368 217
.

ADAP valuation

P/E -2,17
P/B 0,83
P/S 71,17
E/P -46
P/FCF -4,99
.

ADAP profitability

ROE -38%
ROA% -29%
ROIC% -32%